Vistin Pharma ASA (VISTN) — Cash Flow-to-Debt Ratio
Vistin Pharma ASA (VISTN) has a Cash Flow-to-Debt Ratio of 0.05x as of June 2025, meaning its operating cash flow of Nkr6.37 Million could theoretically repay 0% of its total liabilities (Nkr127.45 Million) in one year. See Vistin Pharma ASA (VISTN) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Vistin Pharma ASA Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Vistin Pharma ASA across 9 annual periods. Also explore VISTN net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Vistin Pharma ASA (2016–2024)
Year-by-year debt coverage analysis for Vistin Pharma ASA. For market capitalisation and broader financial context, see Vistin Pharma ASA stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 1.43x | Nkr107.86 Million | Nkr75.42 Million | ▲ +27.3% |
| 2023 | 1.12x | Nkr90.59 Million | Nkr80.63 Million | ▲ +1797.2% |
| 2022 | -0.07x | Nkr-8.87 Million | Nkr133.95 Million | ▼ -127.7% |
| 2021 | 0.24x | Nkr13.68 Million | Nkr57.26 Million | ▲ +108.1% |
| 2020 | -2.94x | Nkr-145.73 Million | Nkr49.51 Million | ▼ -1511.0% |
| 2019 | 0.21x | Nkr18.93 Million | Nkr90.77 Million | ▲ +179.9% |
| 2018 | -0.26x | Nkr-39.48 Million | Nkr151.21 Million | ▼ -406.4% |
| 2017 | 0.09x | Nkr9.51 Million | Nkr111.59 Million | ▼ -85.3% |
| 2016 | 0.58x | Nkr53.84 Million | Nkr92.91 Million | — |